DIBETZA XR Trademark

Trademark Overview

On Friday, December 17, 2021, a trademark application was filed for DIBETZA XR with the United States Patent and Trademark Office. The USPTO has given the DIBETZA XR trademark a serial number of 97176720. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, June 7, 2024. This trademark is owned by Creekwood Pharmaceuticals LLC. The DIBETZA XR trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical agents affecting metabolism
dibetza xr

General Information

Serial Number97176720
Word MarkDIBETZA XR
Filing DateFriday, December 17, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, June 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements

Goods and ServicesDrug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical agents affecting metabolism
Translation of Words in MarkThe wording "DIBETZA" has no meaning in a foreign language.
NOT AVAILABLE"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCreekwood Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDover, DE 19904
Party NameCreekwood Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDover, DE 19904

Trademark Events

Event DateEvent Description
Tuesday, December 21, 2021NEW APPLICATION ENTERED
Tuesday, December 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 22, 2022ASSIGNED TO EXAMINER
Monday, September 26, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, September 26, 2022EXAMINERS AMENDMENT E-MAILED
Monday, September 26, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 26, 2022EXAMINER'S AMENDMENT ENTERED
Monday, September 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 23, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 23, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 23, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 30, 2023SOU EXTENSION 1 FILED
Tuesday, May 30, 2023SOU EXTENSION 1 GRANTED
Thursday, June 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 12, 2023SOU EXTENSION 2 FILED
Tuesday, December 12, 2023SOU EXTENSION 2 GRANTED
Thursday, December 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 7, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 7, 2024SOU EXTENSION 3 FILED
Friday, June 7, 2024SOU EXTENSION 3 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

dibetza agents variety wide pharmaceuticals affecting metabolism ingredients pharmaceutical release form